← All trials
NCT00528593
Phase 2Interventional
Includes controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in participants with the disease or condition under study and to determine the common short-term side effects and risks.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 1, 2007
- Primary completion
- Oct 1, 2009
- Completion date
- Oct 1, 2009
- First posted
- —
- Last posted
- —
- Enrollment
- —
- Arms / groups
- 1 / —
- Source
- AACT · pre-existing
Sponsors
- Washington University in St. LouisLead sponsor
- Northwestern UniversityOverall official - principal investigator
- University of PennsylvaniaOverall official - principal investigator
- University of TorontoOverall official - principal investigator
- Johns Hopkins UniversityStudy chair
- PPDCollaborator
- National Institute of Neurological Disorders and Stroke (NINDS)Collaborator
- Washington University in St. LouisOverall official - principal investigator
- Ortho Biotech, Inc.Collaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.